Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Etodolac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for etodolac and what is the scope of patent protection?

Etodolac
is the generic ingredient in three branded drugs marketed by Sandoz, Apotex Inc, Mylan Pharms Inc, Teva, Mylan, Apotex, Oxford Pharms, Wyeth Pharms Inc, Ani Pharms Inc, Ranbaxy Labs Ltd, Lehigh Valley, Watson Labs Florida, Zydus Pharms Usa Inc, Idt Australia Ltd, Chartwell Molecules, Watson Labs, Taro, Taro Pharm Inds, Ivax Sub Teva Pharms, and Actavis Elizabeth, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for etodolac. Thirty-seven suppliers are listed for this compound.

Summary for Generic Name: etodolac

Tradenames:3
Patents:1
Applicants:20
NDAs:35
Drug Master File Entries: see list22
Suppliers / Packagers: see list37
Bulk Api Vendors: see list56
Clinical Trials: see list14
Patent Applications: see list8,668
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etodolac at DailyMed

Pharmacology for Ingredient: etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex
ETODOLAC
etodolac
CAPSULE;ORAL075419-002Jul 28, 2000ABRXNoNo► Subscribe► Subscribe
Idt Australia Ltd
ETODOLAC
etodolac
CAPSULE;ORAL074840-001Aug 29, 1997DISCNNoNo► Subscribe► Subscribe
Idt Australia Ltd
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075943-003Jul 26, 2002DISCNNoNo► Subscribe► Subscribe
Taro
ETODOLAC
etodolac
CAPSULE;ORAL075078-002Apr 30, 1998ABRXNoYes► Subscribe► Subscribe
Taro Pharm Inds
ETODOLAC
etodolac
TABLET;ORAL075074-002Apr 25, 2000ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot